Trials
Search / Trial NCT00001346

Diabetic Retinopathy and Visual Function Study

Launched by NATIONAL EYE INSTITUTE (NEI) · Dec 9, 2002

Apply for Trial

Trial Information

Current as of January 14, 2025

Completed

Keywords

Diabetic Macular Edema Diabetic Retinopathy Macular Edema Photocoagulation Psychophysical Testing Stiles Crawford Effect

ClinConnect Summary

The purpose of this study is to evaluate possible mechanisms of central visual loss in patients with diabetes mellitus. The visual loss of interest to be investigated is that associated with macular edema (prior to and following laser photocoagulation treatment) and that associated with panretinal photocoagulation. The evaluation will be performed with psychophysical testing, i.e., static perimetry and contrast sensitivity function. Of particular interest, the mechanisms of visual loss associated with macular edema (prior to and following laser photocoagulation) will be further investigated...

Gender

ALL

Eligibility criteria

  • • Patients with diabetic retinopathy that has not been previously treated are eligible for the study.
  • • Patients who have had laser photocoagulation (either focal or scatter) are not eligible.

About National Eye Institute (Nei)

The National Eye Institute (NEI), part of the U.S. National Institutes of Health (NIH), is dedicated to conducting and supporting innovative research to understand, prevent, and treat eye diseases and vision disorders. As a leading sponsor of clinical trials, NEI aims to advance knowledge in ocular health through rigorous scientific inquiry and collaboration with researchers, healthcare professionals, and institutions. By fostering the development of new therapies and technologies, NEI plays a pivotal role in enhancing the quality of life for individuals affected by visual impairments and eye conditions.

Locations

Bethesda, Maryland, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials